Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...

Nov 2024 - Santana Minerals (ASX:SMI) has released its Pre-Feasibility Study (PFS) results for the Bendigo-Ophir Gold Project ...

Barclays raised the firm’s price target on PTC Therapeutics (PTCT) to $43 from $31 and keeps an Equal Weight rating on the shares. The ...

ClearPoint Neuro reported strong YoY growth in Q3, but the stock reacted negatively. Check out my recommendation for CLPT ...

Q3 2024 Earnings Call Transcript November 7, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.39, ...